Total Funding
44
51
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
143836
Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Acquired by 
Sun Pharmaceutical
- James F. Oliviero: President & CEO
Sun Pharmaceutical
About the Company
Checkpoint Therapeutics mainly engages in advancing the development of cancer immunotherapy and targeted oncology treatments. It is dedicated to developing and bringing cancer therapies to market faster and actively pursuing product purchases, in-licensing, and co-development opportunities that align with its areas of expertise. The company
provides a streamlined approach that lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors, and providers benefit from effective and affordable treatment options.
